Literature DB >> 5520996

[Cytostatic therapy in breast carcinoma].

K Karrer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5520996     DOI: 10.1007/bf01259051

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


× No keyword cloud information.
  62 in total

1.  COMBINATION OF CHEMOTHERAPY AND SURGERY IN THE TREATMENT OF CANCER.

Authors:  A L NASR
Journal:  Acta Unio Int Contra Cancrum       Date:  1963

2.  CHEMOTHERAPY OF BREAST CANCER.

Authors:  A R SILVA; C R SMART; D B ROCHLIN
Journal:  Surg Gynecol Obstet       Date:  1965-09

3.  Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in the treatment of far-advanced breast and colon lesions.

Authors:  A R CURRERI; F J ANSFIELD
Journal:  Cancer Chemother Rep       Date:  1962-02

4.  Effects of cancer chemotherapeutic agents on the human fetus.

Authors:  J E SOKAL; E M LESSMANN
Journal:  J Am Med Assoc       Date:  1960-04-16

Review 5.  Use of anticancer drugs during pregnancy.

Authors:  L Stutzman; J E Sokal
Journal:  Clin Obstet Gynecol       Date:  1968-06       Impact factor: 2.190

6.  Cyclophosphamide in the management of advanced breast cancer.

Authors:  C A Joslin; P B Kunkler; I H Evans; V Jones; K Wong
Journal:  Proc R Soc Med       Date:  1970-01

7.  Comparison of methotrexate (NSC-740) and testosterone propionate (NSC-9166) in the treatment of breast cancer.

Authors:  H B Nevinny; T C Hall; C Haines; M J Krant
Journal:  J Clin Pharmacol J New Drugs       Date:  1968 Mar-Apr

8.  Systemic chemotherapy as an adjuvant to surgery in the treatment of breast cancer.

Authors:  B Fisher
Journal:  Cancer       Date:  1969-12       Impact factor: 6.860

9.  Melphalan (NSC-8806) in advanced breast cancer.

Authors:  M E Sears; A Haut; N Eckles
Journal:  Cancer Chemother Rep       Date:  1966-07

10.  [Cytostatic attack treatment in surgery].

Authors:  O Boeckl; K Karrer
Journal:  Chirurg       Date:  1965-11       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.